BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 11645686)

  • 1. Informed consent for human drugs and biologics; determination that informed consent is not feasible; interim rule and opportunity for public comment.
    U.S. Food and Drug Administration
    Fed Regist; 1990 Dec; 55(246):52814-7. PubMed ID: 11645686
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA seeks public comment on informed consent rules in combat situations.
    Hastings Cent Rep; 1997; 27(5):43. PubMed ID: 11645003
    [No Abstract]   [Full Text] [Related]  

  • 3. Doe v. Sullivan.
    U.S. Court of Appeals, District of Columbia Circuit
    Fed Report; 1991 Jul; 938():1370-86. PubMed ID: 11648219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Walking a thin line: distinguishing between research and medical practice during Operation Desert Storm.
    Schuchardt EJ
    Columbia J Law Soc Probl; 1992; 26(1):77-115. PubMed ID: 11651647
    [No Abstract]   [Full Text] [Related]  

  • 5. Protection of human subjects; new drugs for investigational use; conforming amendments; final rule.
    U.S. Food and Drug Administration
    Fed Regist; 1984 Oct; 49(212):43637-8. PubMed ID: 11645532
    [No Abstract]   [Full Text] [Related]  

  • 6. The ethics of troop vaccination.
    N Y Times Web; 1991 Jan; ():A22. PubMed ID: 11646805
    [No Abstract]   [Full Text] [Related]  

  • 7. A military exception to "informed consent": Doe v. Sullivan.
    Moran PJ
    St Johns Law Rev; 1993; 66(3):847-63. PubMed ID: 11652729
    [No Abstract]   [Full Text] [Related]  

  • 8. Military medical research: 1. Are there ethical exceptions?
    Levine C
    IRB; 1989; 11(4):5-7. PubMed ID: 11650244
    [No Abstract]   [Full Text] [Related]  

  • 9. Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations; and clinical investigations which may be reviewed through expedited review procedures.
    U.S. Food and Drug Administration
    Fed Regist; 1981 Jan; 46(17):8942-80. PubMed ID: 11658611
    [No Abstract]   [Full Text] [Related]  

  • 10. Problems of drug testing in children in the United States.
    Yaffe SJ
    Pediatr Pharmacol (New York); 1983; 3(3-4):339-48. PubMed ID: 11659147
    [No Abstract]   [Full Text] [Related]  

  • 11. Informed consent in the clinical research setting: experimentation on human subjects.
    Owens JF
    Med Trial Tech Q; 1987; 33(3):335-50. PubMed ID: 11653829
    [No Abstract]   [Full Text] [Related]  

  • 12. Military medical research: 2. Proving the safety and effectiveness of a nerve gas antidote -- a legal view.
    Cooper RM
    IRB; 1989; 11(4):7-9. PubMed ID: 11650245
    [No Abstract]   [Full Text] [Related]  

  • 13. Human drugs and biologics; determination that informed consent is NOT feasible or is contrary to the best interests of recipients; revocation of 1990 interim final rule; establishment of new interim final rule. Food and Drug Administration, HHS. Interim final rule; opportunity for public comment.
    Fed Regist; 1999 Oct; 64(192):54180-9. PubMed ID: 11010702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Informed consent and investigational new drug abuses in the U.S. military.
    Cummings ML
    Account Res; 2002; 9(2):93-103. PubMed ID: 12625353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of human subjects; informed consent; proposed rule.
    U.S. Food and Drug Administration
    Fed Regist; 1995 Sep; 60(183):49086-103. PubMed ID: 11656433
    [No Abstract]   [Full Text] [Related]  

  • 16. Proposal on waiver of informed consent poses major issues for research ethics.
    Maloney DM
    Hum Res Rep; 1997 Sep; 12(9):1-3. PubMed ID: 11660533
    [No Abstract]   [Full Text] [Related]  

  • 17. Protection of human subjects.
    United States
    Code Fed Regul Shipping; 1982 Oct; Part 46, Sections 46.101 to 46.306():. PubMed ID: 11660819
    [No Abstract]   [Full Text] [Related]  

  • 18. The concept of the IRB and bureaucratic reality: an exchange of letters.
    van Eys J; Levine RJ
    IRB; 1984; 6(4):8-10. PubMed ID: 11649563
    [No Abstract]   [Full Text] [Related]  

  • 19. IRBs and pharmaceutical company funding of research.
    Jellinek MS; Levine RJ
    IRB; 1982 Oct; 4(8):9-10. PubMed ID: 11651693
    [No Abstract]   [Full Text] [Related]  

  • 20. Justiciability--waiving for the flag: should informed consent rules apply in the context of military emergencies?
    Seftel SB
    George Washington Law Rev; 1992 Jun; 60(5):1387-435. PubMed ID: 16086522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.